Efficacy of Calcium Channel Blocker in the Secondary Prevention of Myocardial Infarction-Retrospective Analysis of the 10-Year Prognosis of Coronary Thrombolysis-Treated Patients--Reference-Cited by-同舟云学术

Efficacy of Calcium Channel Blocker in the Secondary Prevention of Myocardial Infarction-Retrospective Analysis of the 10-Year Prognosis of Coronary Thrombolysis-Treated Patients-

Published:2004 Issue:9 Volume:68 Page:853-859
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Tani Shigemasa¹,Watanabe Ikuyoshi¹,Nagao Ken²,Kikushima Kimio¹,Watanabe Kazuhiro¹,Anazawa Takeo¹,Kawamata Hirofumi¹,Tachibana Eizo¹,Furuya Shingo¹,Sasanuma Toshifumi¹,Kushiro Toshio¹,Kanmatsuse Katsuo¹

Affiliation:

1. Division of Cardiology, Department of Internal Medicine, Nihon University School of Medicine and Surugadai Nihon University Hospital

2. Department of Emergency and Critical Care Medicine, Nihon University School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/68/9/68_9_853/_pdf

Reference37 articles.

1. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT).

2. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study